| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |